{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:05Z","timestamp":1740149825675,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12328-023-01776-z","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T08:02:36Z","timestamp":1677916956000},"page":"432-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune thrombocytopenic purpura in primary biliary cholangitis and localized cutaneous systemic sclerosis: case report and literature review"],"prefix":"10.1007","volume":"16","author":[{"given":"Taiki","family":"Okumura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1481-1029","authenticated-orcid":false,"given":"Takefumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuaki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Joshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"key":"1776_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12328-017-0799-z","volume":"11","author":"S Joshita","year":"2018","unstructured":"Joshita S, Umemura T, Tanaka E, et al. Genetics and epigenetics in the pathogenesis of primary biliary cholangitis. Clin J Gastroenterol. 2018;11:11\u20138.","journal-title":"Clin J Gastroenterol"},{"key":"1776_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/hepr.13584","volume":"51","author":"K Kawata","year":"2021","unstructured":"Kawata K, Joshita S, Shimoda S, et al. The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis. Hepatol Res. 2021;51:80\u20139.","journal-title":"Hepatol Res"},{"key":"1776_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases. Hepatology. 2019;69:394\u2013419.","journal-title":"Hepatology"},{"key":"1776_CR4","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","volume":"377","author":"C Selmi","year":"2011","unstructured":"Selmi C, Bowlus CL, Gershwin ME, et al. Primary biliary cirrhosis. Lancet. 2011;377:1600\u20139.","journal-title":"Lancet"},{"key":"1776_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ajg.2015.118","volume":"110","author":"T Umemura","year":"2015","unstructured":"Umemura T, Joshita S, Sekiguchi T, et al. Serum Wisteria floribunda agglutinin-positive mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis. Am J Gastroenterol. 2015;110:857\u201364.","journal-title":"Am J Gastroenterol"},{"key":"1776_CR6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.5009\/gnl16365","volume":"11","author":"SL Chalifoux","year":"2017","unstructured":"Chalifoux SL, Konyn PG, Choi G, et al. Extrahepatic manifestations of primary biliary cholangitis. Gut Liver. 2017;11:771\u201380.","journal-title":"Gut Liver"},{"key":"1776_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/hep.24705","volume":"55","author":"T Umemura","year":"2012","unstructured":"Umemura T, Joshita S, Ichijo T, et al. Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis. Hepatology. 2012;55:506\u201311.","journal-title":"Hepatology"},{"key":"1776_CR8","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685\u201399.","journal-title":"Lancet"},{"key":"1776_CR9","first-page":"183","volume":"153","author":"O Meyer","year":"2002","unstructured":"Meyer O. CREST syndrome. Ann Med Interne (Paris). 2002;153:183\u20138.","journal-title":"Ann Med Interne (Paris)"},{"key":"1776_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/08830189509056707","volume":"12","author":"FC Arnett","year":"1995","unstructured":"Arnett FC. HLA and autoimmunity in scleroderma (systemic sclerosis). Int Rev Immunol. 1995;12:107\u201328.","journal-title":"Int Rev Immunol"},{"key":"1776_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3109\/s10165-012-0607-z","volume":"22","author":"S Imura-Kumada","year":"2012","unstructured":"Imura-Kumada S, Hasegawa M, Matsushita T, et al. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis. Mod Rheumatol. 2012;22:892\u20138.","journal-title":"Mod Rheumatol"},{"key":"1776_CR12","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"1776_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"1776_CR14","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.2169\/internalmedicine.48.2687","volume":"48","author":"M Toyoda","year":"2009","unstructured":"Toyoda M, Yokomori H, Kaneko F, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome concomitant with systemic sclerosis, immune thrombocytopenic purpura. Intern Med. 2009;48:2019\u201323.","journal-title":"Intern Med"},{"key":"1776_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.1840180113","volume":"18","author":"T Seki","year":"1993","unstructured":"Seki T, Kiyosawa K, Ota M, et al. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology. 1993;18:73\u20138.","journal-title":"Hepatology"},{"key":"1776_CR16","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood.V91.10.3616","volume":"91","author":"S Nomura","year":"1998","unstructured":"Nomura S, Matsuzaki T, Ozaki Y, et al. Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Blood. 1998;91:3616\u201322.","journal-title":"Blood"},{"key":"1776_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2169\/internalmedicine.38.336","volume":"38","author":"M Kuwana","year":"1999","unstructured":"Kuwana M, Inoko H, Kameda H, et al. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern Med. 1999;38:336\u201344.","journal-title":"Intern Med"},{"key":"1776_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/BF02389532","volume":"31","author":"Y Mizukami","year":"1996","unstructured":"Mizukami Y, Ohhira M, Matsumoto A, et al. Primary biliary cirrhosis associated with idiopathic thrombocytopenic purpura. J Gastroenterol. 1996;31:284\u20138.","journal-title":"J Gastroenterol"},{"key":"1776_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s005350170133","volume":"36","author":"T Takahashi","year":"2001","unstructured":"Takahashi T, Saitoh T, Imai K. Idiopathic thrombocytopenic purpura complicated with asymptomatic primary biliary cirrhosis. J Gastroenterol. 2001;36:214\u20135.","journal-title":"J Gastroenterol"},{"key":"1776_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00535-003-1322-5","volume":"39","author":"Y Arakawa","year":"2004","unstructured":"Arakawa Y, Amaki S, Miyakawa H, et al. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto\u2019s disease with positivity for anti-centromere antibody. J Gastroenterol. 2004;39:490\u20135.","journal-title":"J Gastroenterol"},{"key":"1776_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2006.00831.x","author":"A Azad","year":"2006","unstructured":"Azad A, Berera V, Jayarajan J, et al. Evans syndrome and primary biliary cirrhosis. Int J Lab Haematol. 2006. https:\/\/doi.org\/10.1111\/j.1751-553X.2006.00831.x.","journal-title":"Int J Lab Haematol"},{"key":"1776_CR22","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3748\/wjg.14.2451","volume":"14","author":"N Toshikuni","year":"2008","unstructured":"Toshikuni N, Yamato R, Kobashi H, et al. Association of primary biliary cirrhosis with idiopathic thrombocytopenic purpura. World J Gastroenterol. 2008;14:2451\u20133.","journal-title":"World J Gastroenterol"},{"key":"1776_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/s10165-010-0397-0","volume":"21","author":"Y Kurihara","year":"2011","unstructured":"Kurihara Y, Shishido T, Oku K, et al. Polymyositis associated with autoimmune hepatitis, primary biliary cirrhosis, and autoimmune thrombocytopenic purpura. Mod Rheumatol. 2011;21:325\u20139.","journal-title":"Mod Rheumatol"},{"key":"1776_CR24","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.2169\/internalmedicine.51.7327","volume":"51","author":"I Naitoh","year":"2012","unstructured":"Naitoh I, Nakazawa T, Hayashi K, et al. A case of IgG4-related sclerosing cholangitis overlapped with primary biliary cirrhosis. Intern Med. 2012;51:1695\u20139.","journal-title":"Intern Med"},{"key":"1776_CR25","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.clinre.2012.11.001","volume":"37","author":"H Korkmaz","year":"2013","unstructured":"Korkmaz H, Bugdaci MS, Temel T, et al. Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome). Clin Res Hepatol Gastroenterol. 2013;37:e45-50.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1776_CR26","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2169\/internalmedicine.54.4405","volume":"54","author":"R Koyamada","year":"2015","unstructured":"Koyamada R, Higuchi T, Kitada A, et al. Association of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome with immune thrombocytopenia and graves\u2019 disease. Intern Med. 2015;54:2013\u20136.","journal-title":"Intern Med"},{"key":"1776_CR27","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2169\/internalmedicine.55.6202","volume":"55","author":"M Takasumi","year":"2016","unstructured":"Takasumi M, Miyata M, Kuroda M, et al. Overlap of IgG4-related disease and primary biliary cirrhosis complicated with autoimmune thrombocytopenia. Intern Med. 2016;55:1387\u201392.","journal-title":"Intern Med"},{"key":"1776_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/hepr.13342","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Mori M, Matsumoto K, et al. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res. 2019;49:881\u20139.","journal-title":"Hepatol Res"},{"key":"1776_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0896-8411(05)80014-9","volume":"3","author":"S Panzer","year":"1990","unstructured":"Panzer S, Penner E, Nelson PJ, et al. Identification of the platelet glycoprotein IIb\/IIIa complex as a target antigen in primary biliary cirrhosis-associated autoimmune thrombocytopenia. Evidence that platelet-reactive autoantibodies can also bind to the mitochondrial antigen M2. J Autoimmun. 1990;3:473\u201383.","journal-title":"J Autoimmun"},{"key":"1776_CR30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/hep.510250607","volume":"25","author":"SM Feistauer","year":"1997","unstructured":"Feistauer SM, Penner E, Mayr WR, et al. Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology. 1997;25:1343\u20135.","journal-title":"Hepatology"},{"key":"1776_CR31","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.15214","volume":"36","author":"C Efe","year":"2021","unstructured":"Efe C, Torgutalp M, Henriksson I, et al. Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome. J Gastroenterol Hepatol. 2021;36:936\u201342.","journal-title":"J Gastroenterol Hepatol"},{"key":"1776_CR32","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1182\/blood.V98.6.1760","volume":"98","author":"R Diz-K\u00fc\u00e7\u00fckkaya","year":"2001","unstructured":"Diz-K\u00fc\u00e7\u00fckkaya R, Hacihanefio\u011flu A, Yenerel M, et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood. 2001;98:1760\u20134.","journal-title":"Blood"},{"key":"1776_CR33","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1365-2141.2008.07228.x","volume":"142","author":"C Pierrot-Deseilligny Despujol","year":"2008","unstructured":"Pierrot-Deseilligny Despujol C, Michel M, Khellaf M, et al. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol. 2008;142:638\u201343.","journal-title":"Br J Haematol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01776-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-023-01776-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01776-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T13:13:07Z","timestamp":1684588387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-023-01776-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1776"],"URL":"https:\/\/doi.org\/10.1007\/s12328-023-01776-z","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"29 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The written informed consent was obtained from patients for this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}